Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Tonix Pharmaceuticals Holding (TNXP) Shares Repurchased (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Shares Repurchased data on record, last reported at $1.9 million in Q3 2025.

  • For Q3 2025, Shares Repurchased rose 85.26% year-over-year to $1.9 million; the TTM value through Sep 2025 reached $5.1 million, down 58.38%, while the annual FY2024 figure was $4.8 million, 65.79% down from the prior year.
  • Shares Repurchased reached $1.9 million in Q3 2025 per TNXP's latest filing, up from $1.4 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $8.4 million in Q4 2023 and bottomed at $882000.0 in Q1 2025.
  • Average Shares Repurchased over 3 years is $2.1 million, with a median of $1.4 million recorded in 2025.
  • Peak YoY movement for Shares Repurchased: crashed 89.38% in 2024, then soared 85.26% in 2025.
  • A 3-year view of Shares Repurchased shows it stood at $8.4 million in 2023, then plummeted by 89.38% to $894000.0 in 2024, then surged by 115.1% to $1.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Repurchased were $1.9 million in Q3 2025, $1.4 million in Q2 2025, and $882000.0 in Q1 2025.